Abstract:Background Lipoprotein lipase (LPL) deficiency, the most common familial chylomicronemia syndrome (FCS), is a rare autosomal recessive disease characterized by chylomicronemia and severe hypertriglyceridemia (HTG), with limited clinical and genetic characterization. Objective To describe the manifestations and management of 19 pediatric patients with LPL-FCS. Methods LPL-FCS patients from 2014 to 2022 were divided into low-fat (LF), very-low-fat (VLF) and medium-chain-triglyceride (MCT) groups. Their clinical data were evaluated to investigate the effect of different diets. The genotype-phenotype relationship was assessed. Linear regression comparing long-chain triglyceride (LCT) intake and TG levels was analyzed. Results Nine novel LPL variants were identified in 19 LPL-FCS pediatric patients. At baseline, eruptive xanthomas occurred in 3/19 patients, acute pancreatitis in 2/19, splenomegaly in 6/19 and hepatomegaly in 3/19. The median triglyceride (TG) level (30.3mmol/L) was markedly increased. The MCT group and VLF group with LCT intakes <20 en% (energy percentage) had considerably lower TG levels than the LF group (both p <0.05). The LF group presented with severe HTG and significantly decreased TG levels after restricting LCT intakes to <20 en% ( p <0.05). Six infants decreased TG levels to <10 mmol/L by keeping LCT intake <10 en%. TG levels and LCT intake were positively correlated in both patients under 2 years (r=0.84) and those aged 2-9 years (r=0.89). No genotype-phenotype relationship was observed. Conclusions This study broadens the clinical and genetic spectra of LPL-FCS. The primary therapy for LPL-FCS pediatric patients is restricting dietary LCTs to <10 en% or <20 en% depending on different ages. MCTs potentially provide extra energy. Abbreviations : AP, acute pancreatitis; apo, apolipoprotein; ACMG, American College of Medical Genetics and Genomics; apo, apolipoprotein; BMI, body mass index; en%, energy percentage; E, exon; ES, exome sequencing; FCS, familial chylomicronemia syndrome; GPIHBP1, glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1; HTG, hypertriglyceridemia; HEK, human embryonic kidney; HDL-C, high-density lipoprotein cholesterol; IQR, interquartile ranges; kcal, kilocalorie; LPL, lipoprotein lipase; LF, low fat; LCT, long-chain triglyceride; LMF1, lipase maturation factor 1; LDL-C, low-density lipoprotein cholesterol; LP, likely pathogenic; MCT, medium-chain triglyceride; MCS, multifactorial chylomicronemia syndrome; P, pathogenic; qPCR, quantitative polymerase chain reaction; SDS, standard deviation score; SD, standard deviation; TC, total cholesterol; TG, triglyceride; VLF, very low fat

Significant but partial lipoprotein lipase functional loss caused by a novel occurrence of rare LPL biallelic variants

Identification and Functional Characterization of a Novel Heterozygous Missense Variant in the LPL Associated with Recurrent Hypertriglyceridemia‐induced Acute Pancreatitis in Pregnancy

Identification and functional characterization of mutations in LPL gene causing severe hypertriglyceridaemia and acute pancreatitis.

Identification of a Novel LPL Nonsense Variant and Further Insights into the Complex Etiology and Expression of Hypertriglyceridemia-Induced Acute Pancreatitis

Compound but Non-Linked Heterozygous P.w14x and P.l279 V LPL Gene Mutations in a Chinese Patient with Long-Term Severe Hypertriglyceridemia and Recurrent Acute Pancreatitis.

A Novel Lipoprotein Lipase Gene Missense Mutation in Chinese Patients with Severe Hypertriglyceridemia and Pancreatitis

Case Report: Next-Generation Sequencing Identified a Novel Pair of Compound-Heterozygous Mutations of LPL Gene Causing Lipoprotein Lipase Deficiency

Association of lipoprotein lipase (LPL) gene variants with hyperlipidemic acute pancreatitis in southeastern Chinese population

Analysis of a Chinese Pedigree With Familial Chylomicronemia Syndrome Reveals Two Novel LPL Mutations by Whole-Exome Sequencing.

Identification and functional analysis of novel homozygous LMF1 variants in severe hypertriglyceridemia

Identification and Characterization of Two Novel Compounds: Heterozygous Variants of Lipoprotein Lipase in Two Pedigrees With Type I Hyperlipoproteinemia

Clinical Profile, Genetic Spectrum and Therapy Evaluation of 19 Chinese Pediatric Patients with Lipoprotein Lipase Deficiency

Frameshift Coding Sequence Variants in the LPL Gene: Identification of Two Novel Events and Exploration of the Genotype–phenotype Relationship for Variants Reported to Date

Genetic and biochemical analysis of severe hypertriglyceridemia complicated with acute pancreatitis or with low post-heparin lipoprotein lipase mass

Identification of a Compound Heterozygous LMF1 Variants in a Patient with Severe Hypertriglyceridemia – Case Report and Literature Review

A Heterozygous LMF1 Gene Mutation (c.1523C>T), Combined With an LPL Gene Mutation (c.590G>A), Aggravates the Clinical Symptoms in Hypertriglyceridemia

Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells.

Identification of a Novel Mutation at the Point of Low Density Lipoprotein Receptor Gene from a Subject with Familial Hypercholesterolemia

Sequencing of Lipoprotein Lipase Gene in 11 Cases of Chinese Patients with Severe Endogenous Hypertriglyceridemia.

Phenotype in Individuals with Heterozygous Rare Variants in LIPC Encoding Hepatic Lipase

Gestational hyperlipidemia and acute pancreatitis with underlying partial lipoprotein lipase deficiency and apolipoprotein E3/E2 genotype